⌘K

Login Start Free

Home/Filings/4/0001600132-19-000125

4//SEC Filing

BENNETT MATTHEW 4

Accession 0001600132-19-000125

CIK 0001600132other

View on SEC.gov Company Profile

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 4:48 PM ET

Size

5.2 KB

Accession

0001600132-19-000125

Insider Transaction Report

Form 4

Period: 2019-09-26

Bellerophon Therapeutics, Inc.BLPH

BENNETT MATTHEW

Director

Transactions

Award
Stock Option (right to buy)
2019-09-26+46,266→ 84,482 total
Exercise: $0.50From: 2020-09-26Exp: 2029-09-26→ Common Stock (46,266 underlying)

Documents

1 file

4
wf-form4_156987648053415.xmlPrimary
FORM 4

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1

filerCIK 0001267642

Filing Metadata

Form type: 4
Filed: Sep 29, 8:00 PM ET
Accepted: Sep 30, 4:48 PM ET
Size: 5.2 KB

View on SEC.gov